fluoxetine has been researched along with Chronic Kidney Failure in 7 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Guidelines suggest treatment of depression in dialysis patients with pharmacological therapy, preferably a selective serotonin reuptake inhibitor." | 2.53 | Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis. ( Craig, JC; Natale, P; Palmer, SC; Rabindranath, KS; Ruospo, M; Saglimbene, VM; Strippoli, GF, 2016) |
"Nonsudden cardiac death was treated as a competing event." | 1.51 | Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis. ( Assimon, MM; Brookhart, MA; Flythe, JE, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ratnapala, US | 1 |
Yucel-Finn, A | 1 |
Walbaum, D | 1 |
Dempsey, O | 1 |
Assimon, MM | 1 |
Brookhart, MA | 1 |
Flythe, JE | 1 |
Palmer, SC | 1 |
Natale, P | 1 |
Ruospo, M | 1 |
Saglimbene, VM | 1 |
Rabindranath, KS | 1 |
Craig, JC | 1 |
Strippoli, GF | 1 |
Finkelstein, FO | 1 |
Watnick, S | 1 |
Finkelstein, SH | 1 |
Wuerth, D | 1 |
Levy, NB | 2 |
Blumenfield, M | 2 |
Beasley, CM | 2 |
Dubey, AK | 2 |
Solomon, RJ | 2 |
Todd, R | 2 |
Goodman, A | 2 |
Bergstrom, RR | 1 |
Spinowitz, B | 1 |
Charytan, C | 1 |
Bergstrom, RF | 1 |
Luft, FC | 1 |
Aronoff, GR | 1 |
Sloan, RS | 1 |
Fineberg, NS | 1 |
2 reviews available for fluoxetine and Chronic Kidney Failure
Article | Year |
---|---|
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.
Topics: Adult; Antidepressive Agents; Citalopram; Depression; Fluoxetine; Humans; Kidney Failure, Chronic; P | 2016 |
The treatment of depression in patients maintained on dialysis.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Fluoxetine; Humans; Kidney Failu | 2002 |
1 trial available for fluoxetine and Chronic Kidney Failure
Article | Year |
---|---|
Fluoxetine in depressed patients on dialysis.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Double-Blind Meth | 1997 |
4 other studies available for fluoxetine and Chronic Kidney Failure
Article | Year |
---|---|
A puzzling pneumonia in a young immunosuppressed man.
Topics: Adult; Depressive Disorder; Diagnosis, Differential; Fluoxetine; Humans; Immunocompromised Host; Kid | 2018 |
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, | 2019 |
Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationsh | 1996 |
Intra- and interindividual variability in sodium intake in normal subjects and in patients with renal insufficiency.
Topics: Adolescent; Adult; Creatinine; Electrolytes; Fluoxetine; Homeostasis; Humans; Kidney Failure, Chroni | 1986 |